Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
BIBio-Rad Laboratories, Inc. logo

Bio-Rad Laboratories, Inc. (BIO)

New York Stock Exchange · Currency in USD
$369.95 ▲ +6.45 (+1.77%)
At close: Oct 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$363.50
Open
$356.98
Day's Range
$356.57 – $371.31
52 Week Range
$236.73 – $396.23
Volume
167,405
Avg. Volume
280,598
Market Cap
$9.89B
Beta (5Y Monthly)
1.07
PE Ratio (TTM)
44.41
EPS (TTM)
$8.32
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$350.00

Profile: Bio-Rad Laboratories, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
7,450
CEO
Norman D. Schwartz

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate $2.23 · Revenue est. $649.95M
DateEst.Actual
Aug 4, 2026$1.75$2.62Beat
Apr 30, 2026$1.97$1.89Miss
Feb 12, 2026$2.57$2.51Miss
Oct 29, 2025$2.30$2.26Miss
Jul 31, 2025$1.93$2.61Beat
May 1, 2025$1.73$2.54Beat

Analyst view

Consensus price target
$350.00 ▼ -5.4%
Range $310.00 – $390.00
Rating: Buy
Buy 57% · Hold 43% · Sell 0%

Get free alerts on BIO and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.